Patents by Inventor Shaun A. Kirkpatrick

Shaun A. Kirkpatrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
    Patent number: 7399751
    Abstract: The present invention provides a method of providing an individual with a biological factor or intermediate thereof which comprises introducing into the individual Sertoli cells genetically altered to produce the biological factor or intermediate thereof. The genetically altered Sertoli cells are administered in an amount effective to produce the desired effect. Aside from producing the biological factor or intermediate thereof, the engineered Sertoli cells also create an immunologically privileged site. Vectors comprising a promoter which functions in Sertoli cells operably linked to coding sequence for a desired biological factor are also provided as are Sertoli cells comprising such vectors. A pharmaceutical composition comprising Sertoli cells genetically altered to produce a biological factor is also provided.
    Type: Grant
    Filed: August 15, 2002
    Date of Patent: July 15, 2008
    Assignee: Sertoli Technologies, Inc.
    Inventors: Shaun A. Kirkpatrick, Paul Gores, Craig Halberstadt
  • PRODUCTION OF A BIOLOGICAL FACTOR AND CREATION OF AN IMMUNOLOGICALLY PRIVILEGED ENVIRONMENT USING GENETICALLY ALTERED SERTOLI CELLS
    Publication number: 20080145348
    Abstract: The present invention provides a method of providing an individual with a biological factor or intermediate thereof which comprises introducing into the individual Sertoli cells genetically altered to produce the biological factor or intermediate thereof. The genetically altered Sertoli cells are administered in an amount effective to produce the desired effect. Aside from producing the biological factor or intermediate thereof, the engineered Sertoli cells also create an immunologically privileged site. Vectors comprising a promoter which functions in Sertoli cells operably linked to coding sequence for a desired biological factor are also provided as are Sertoli cells comprising such vectors. A pharmaceutical composition comprising Sertoli cells genetically altered to produce a biological factor is also provided.
    Type: Application
    Filed: February 20, 2008
    Publication date: June 19, 2008
    Inventors: Shaun A. Kirkpatrick, Paul Gores, Craig Halberstadt
  • Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells
    Publication number: 20020192200
    Abstract: The present invention provides a method of providing an individual with a biological factor or intermediate thereof which comprises introducing into the individual Sertoli cells genetically altered to produce the biological factor or intermediate thereof. The genetically altered Sertoli cells are administered in an amount effective to produce the desired effect. Aside from producing the biological factor or intermediate thereof, the engineered Sertoli cells also create an immunologically privileged site. Vectors comprising a promoter which functions in Sertoli cells operably linked to coding sequence for a desired biological factor are also provided as are Sertoli cells comprising such vectors. A pharmaceutical composition comprising Sertoli cells genetically altered to produce a biological factor is also provided.
    Type: Application
    Filed: August 15, 2002
    Publication date: December 19, 2002
    Inventors: Shaun A. Kirkpatrick, Paul Gores, Craig Halberstadt